3.26
전일 마감가:
$3.31
열려 있는:
$3.27
하루 거래량:
3.44M
Relative Volume:
0.73
시가총액:
$321.37M
수익:
$775.09M
순이익/손실:
$-58.68M
주가수익비율:
-24.59
EPS:
-0.1326
순현금흐름:
$64.06M
1주 성능:
-10.93%
1개월 성능:
-28.04%
6개월 성능:
-30.34%
1년 성능:
-44.46%
Goodrx Holdings Inc Stock (GDRX) Company Profile
명칭
Goodrx Holdings Inc
전화
(855) 268-2822
주소
2701 OLYMPIC BOULEVARD, SANTA MONICA
GDRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
GDRX
Goodrx Holdings Inc
|
3.26 | 1.15B | 775.09M | -58.68M | 64.06M | -0.1326 |
|
VEEV
Veeva Systems Inc
|
293.49 | 47.98B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
84.49 | 15.41B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
65.82 | 12.54B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
95.03 | 8.17B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.49 | 7.08B | 906.14M | -52.62M | 89.62M | -0.3621 |
Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-11 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2024-12-04 | 개시 | Mizuho | Neutral |
| 2024-08-09 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-05-23 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-05-16 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2024-04-10 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-03-25 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-03-01 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2024-01-02 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2023-08-10 | 업그레이드 | DA Davidson | Neutral → Buy |
| 2023-07-31 | 업그레이드 | TD Cowen | Market Perform → Outperform |
| 2022-12-01 | 개시 | Citigroup | Buy |
| 2022-11-04 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | 개시 | Truist | Hold |
| 2022-08-12 | 개시 | DA Davidson | Neutral |
| 2022-06-10 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-06-06 | 재개 | BofA Securities | Buy |
| 2022-06-01 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2022-05-10 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-05-10 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-05-10 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2022-05-10 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-11 | 개시 | Wells Fargo | Equal Weight |
| 2022-04-07 | 개시 | Guggenheim | Buy |
| 2022-04-01 | 재개 | Credit Suisse | Neutral |
| 2022-03-15 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2022-03-01 | 재확인 | Barclays | Overweight |
| 2022-03-01 | 재확인 | BofA Securities | Neutral |
| 2022-03-01 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2022-03-01 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2022-03-01 | 재확인 | Evercore ISI | Outperform |
| 2022-03-01 | 재확인 | Goldman | Buy |
| 2022-03-01 | 재확인 | JP Morgan | Underweight |
| 2022-03-01 | 재확인 | RBC Capital Mkts | Outperform |
| 2022-03-01 | 재확인 | SVB Leerink | Outperform |
| 2022-01-07 | 개시 | Goldman | Buy |
| 2021-12-21 | 개시 | Stephens | Overweight |
| 2021-12-02 | 개시 | Jefferies | Buy |
| 2021-08-31 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2021-08-13 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2021-05-28 | 개시 | Robert W. Baird | Neutral |
| 2021-04-06 | 재개 | Evercore ISI | Outperform |
| 2021-01-25 | 개시 | Guggenheim | Buy |
| 2020-11-19 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-11-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-10-19 | 개시 | Barclays | Equal Weight |
| 2020-10-19 | 개시 | BofA Securities | Neutral |
| 2020-10-19 | 개시 | Citigroup | Buy |
| 2020-10-19 | 개시 | Cowen | Outperform |
| 2020-10-19 | 개시 | Credit Suisse | Outperform |
| 2020-10-19 | 개시 | Deutsche Bank | Hold |
| 2020-10-19 | 개시 | Goldman | Neutral |
| 2020-10-19 | 개시 | JP Morgan | Neutral |
| 2020-10-19 | 개시 | Morgan Stanley | Overweight |
| 2020-10-19 | 개시 | RBC Capital Mkts | Sector Perform |
| 2020-10-19 | 개시 | SVB Leerink | Outperform |
| 2020-10-19 | 개시 | UBS | Buy |
모두보기
Goodrx Holdings Inc 주식(GDRX)의 최신 뉴스
GoodRx Holdings Inc reports results for the quarter ended September 30Earnings Summary - TradingView
GoodRx Holdings Inc Q3 2025 Earnings: Revenue Beats at $196M, EPS Misses Estimate at $0.00 - GuruFocus
Digital healthcare firm GoodRx beats Q3 revenue estimates, maintains 2025 revenue forecast - MarketScreener
GoodRx (GDRX) Forecasts Revenue Growth for Fiscal Year 2025 - GuruFocus
GoodRx (GDRX) Exceeds Q3 Revenue Expectations - GuruFocus
GoodRx’s (NASDAQ:GDRX) Q3 Sales Top Estimates - Yahoo Finance
GoodRx Holdings, Inc. (GDRX) Misses Q3 EPS by 1c, Beats on Revenue - StreetInsider
Goodrx stock hits 52-week low at 3.3 USD By Investing.com - Investing.com Australia
GoodRx Holdings Inc (GDRX) Q3 2025 Earnings Report Preview: What To Look For - Yahoo Finance
Ranking GoodRx Holdings Inc. among high performing stocks via tools2025 Price Action Summary & Weekly Consistent Profit Watchlists - newser.com
Using Ichimoku Cloud for GoodRx Holdings Inc. technicals2025 Top Gainers & Community Verified Swing Trade Signals - newser.com
Quantitative breakdown of GoodRx Holdings Inc. recent movePortfolio Gains Report & Reliable Breakout Stock Forecasts - newser.com
Can GoodRx Holdings Inc. stock double in next 5 yearsEarnings Beat & AI Enhanced Trading Alerts - newser.com
Real time social sentiment graph for GoodRx Holdings Inc.Earnings Recap Summary & AI Driven Stock Movement Reports - newser.com
GoodRx Holdings Co-Chairman Trevor Bezdek Steps Down - TipRanks
GoodRx Holdings Announces Management Change - TradingView
Goodrx stock hits 52-week low at 3.3 USD - Investing.com
GoodRx Holdings Inc (GDRX) Q3 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Is GoodRx Holdings Inc. still worth holding after the dipJuly 2025 Final Week & Daily Profit Focused Stock Screening - newser.com
Custom watchlist performance reports with GoodRx Holdings Inc.Rate Hike & High Return Stock Watch Alerts - newser.com
Does GoodRx Holdings Inc. fit your quant trading model2025 Risk Factors & Expert Curated Trade Setups - newser.com
How strong is GoodRx Holdings Inc. stock revenue growthRate Cut & Expert Curated Trade Setup Alerts - newser.com
Smart tools for monitoring GoodRx Holdings Inc.’s price actionMarket Sentiment Report & Growth Focused Stock Reports - newser.com
Risk adjusted return profile for GoodRx Holdings Inc. analyzed2025 Geopolitical Influence & Consistent Profit Trade Alerts - newser.com
Measuring GoodRx Holdings Inc.’s beta against major indicesPortfolio Return Summary & Safe Entry Zone Identification - newser.com
Real time breakdown of GoodRx Holdings Inc. stock performanceGDP Growth & Weekly Market Pulse Updates - newser.com
Reversal indicators forming on GoodRx Holdings Inc. stockJuly 2025 Intraday Action & Growth Focused Entry Point Reports - newser.com
Is GoodRx Holdings Inc. meeting your algorithmic filter criteriaWeekly Stock Summary & Short-Term Trading Opportunity Alerts - newser.com
Detecting price anomalies in GoodRx Holdings Inc. with AIPortfolio Return Report & Free Expert Approved Momentum Trade Ideas - newser.com
Does GoodRx Holdings Inc. qualify in momentum factor screeningBond Market & Community Shared Stock Ideas - newser.com
GoodRx (GDRX) Q3 Earnings Report Preview: What To Look For - Barchart.com
Goodrx Holdings Inc (GDRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):